Name | Revaprazan Hydrochloride |
---|---|
Synonyms |
T66 CNT&J B1 C- DT6N CNJ BMR DF& E1 F1 &&HCl
N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-2(1H)-isoquinolinyl)-2-pyrimidinamine hydrochloride (1:1) 4-(3,4-Dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-2-pyrimidinamine, monohydrochloride N-(4-Fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)pyrimidin-2-amine hydrochloride Revanex 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, monohydrochloride Revaprazan HCL 2-Pyrimidinamine, 4-(3,4-dihydro-1-methyl-2(1H)-isoquinolinyl)-N-(4-fluorophenyl)-5,6-dimethyl-, hydrochloride (1:1) YH1885 |
Description | Revaprazan hydrochloride is a novel acid pump antagonist (APA). Revaprazan hydrochloride reduces COX-2 expression and has significant anti-inflammatory actions activities in H. pylori infection[1]. |
---|---|
Related Catalog | |
Target |
Acid pump; COX-2[1] |
References |
Melting Point | 205-208° |
---|---|
Molecular Formula | C22H24ClFN4 |
Molecular Weight | 398.904 |
Exact Mass | 398.167358 |
PSA | 41.05000 |
LogP | 6.03980 |
Storage condition | 2-8°C |